文献速递衰弱、肌少症与跌倒老年慢病共病管理

卒中前衰弱对卒中幸存者全因死亡率的影响:系统综述与剂量反应Meta分析

Impact of pre-existing frailty on all-cause mortality in stroke survivors: a systematic review and dose-response meta-analysis.
PubMed 文献 · Age Ageing · 2025-01-01

结果显示卒中前衰弱显著增加全因死亡风险(合并HR=2.19,95%CI 1.44-3.34),衰弱评分每增加1分死亡风险增加6.4%(HR=1.064,95%CI 1.031-1.098),呈线性剂量反应关系。

要点

  • 卒中前衰弱显著增加卒中幸存者全因死亡风险,合并HR为2.19。
  • 衰弱评分每增加1分,死亡风险线性增加6.4%。
  • 急性缺血性卒中人群中关联更强(OR=3.43)。

核心结论

  • 卒中前衰弱独立预测卒中幸存者全因死亡率,即使衰弱程度轻度增加也与更差结局相关。
  • 建议将衰弱评估纳入卒中患者预后评价。

研究设计与样本

  • 系统综述与剂量反应Meta分析,检索PubMed、Embase、Web of Science、Cochrane Library、CINAHL、PsycINFO、CNKI、万方、维普及SinoMed数据库至2024年11月12日。
  • 纳入使用经验证衰弱评估工具并报告校正后风险比(HR)或比值比(OR)及95%置信区间(CI)的研究。

主要发现

  • 卒中幸存者中衰弱患病率为11.2%至75.3%。
  • 卒中前衰弱与全因死亡率增加显著相关(合并HR=2.19,95%CI 1.44-3.34)。
  • 连续衰弱评分的合并OR为1.26(95%CI 1.14-1.38)。
  • 剂量反应分析显示线性关系,衰弱评分每增加1分死亡风险增加6.4%(HR=1.064,95%CI 1.031-1.098)。
  • 亚组分析显示急性缺血性卒中人群中关联尤为显著(OR=3.43,95%CI 1.81-6.51)。

关键数值与推荐

  • 衰弱评估工具类型和研究样本量被确定为异质性的潜在来源。

临床怎么用

  • 在卒中幸存者预后评估中应纳入卒中前衰弱评估,以识别高死亡风险患者。

局限性

  • 衰弱评估工具类型和研究样本量是异质性的潜在来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The association between pre-existing frailty and increased mortality in stroke survivors remains unclear, with prior studies reporting inconsistent findings. This meta-analysis aimed to evaluate the impact of pre-stroke frailty on all-cause mortality in this population. METHODS: We systematically searched PubMed, Embase, Web of Science, Cochrane Library, CINAHL, PsycINFO, CNKI, Wanfang, VIP, and SinoMed databases up to November 12, 2024. Study selection and data extraction were independently performed by two investigators. Studies using validated frailty assessment tools and reporting adjusted hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were included. RESULTS: Sixteen studies involving 55,897 patients met the inclusion criteria. The prevalence of frailty among stroke survivors ranged from 11.2% to 75.3%. Meta-analysis showed that pre-stroke frailty was significantly associated with increased all-cause mortality (pooled HR = 2.19, 95% CI: 1.44-3.34; pooled OR for continuous frailty scores = 1.26, 95% CI: 1.14-1.38). Dose-response analysis revealed a linear relationship, with each one-point increase in frailty score associated with a 6.4% higher risk of death (HR = 1.064, 95% CI: 1.031-1.098). Subgroup analyses indicated that the association was particularly strong in acute ischemic stroke populations (OR = 3.43, 95% CI: 1.81-6.51). The type of frailty assessment tool and study sample size were identified as potential sources of heterogeneity. CONCLUSION: Pre-stroke frailty independently predicts all-cause mortality in stroke survivors. Even mild increases in frailty burden are associated with worse outcomes, highlighting the clinical importance of incorporating frailty assessment into prognostic evaluation.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Wang S, Tan J, Song K, et al. Impact of pre-existing frailty on all-cause mortality in stroke survivors: a systematic review and dose-response meta-analysis. Age Ageing. 2025. PMID: 41014508. doi:10.1093/ageing/afaf273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。